Safety of treatments for primary Sjögren's syndrome.
van Nimwegen JF, Moerman RV, Sillevis Smitt N, Brouwer E, Bootsma H, Vissink A.
van Nimwegen JF, et al. Among authors: moerman rv.
Expert Opin Drug Saf. 2016;15(4):513-24. doi: 10.1517/14740338.2016.1146676. Epub 2016 Feb 16.
Expert Opin Drug Saf. 2016.
PMID: 26809028
Free article.
Review.